As suggested by Lee et al., creating an algorithm where IL-6 blockade is used as the first line therapy for treatment of severe CRS can systematically guide therapy for CRS perhaps avoiding mortality (75). The gene discussed is IL6; the disease is congenital rubella syndrome.